Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartmann

Showing results (511-520 of 626) with videos related to

Pageof 63
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancerFritcher Emily G Barr, Amy C Degnim, Lynn C Hartmann, et al.
Gynecologic Oncology|May 8, 2009
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancerAbraham Peedicayil, Robert A Vierkant, Vijayalakshmi Shridhar, et al.
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Breast Cancer Research and Treatment|August 13, 2015
Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort StudyAziza Nassar, Daniel W Visscher, Amy C Degnim, et al.
Frontiers in Immunology|November 16, 2020
Analysis of Granulomatous Lymphocytic Interstitial Lung Disease Using Two Scoring Systems for Computed Tomography Scans-A Retrospective Cohort StudyJennifer J Meerburg, Ieneke J C Hartmann, Sigune Goldacker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2001
Cigarette smoking increases risk for breast cancer in high-risk breast cancer familiesF J Couch, J R Cerhan, R A Vierkant, et al.
Cancer|June 29, 2016
Breast cancer risk by the extent and type of atypical hyperplasiaAmy C Degnim, Daniel W Visscher, Derek C Radisky, et al.
Gynecologic Oncology|April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinomaS John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Mayo Clinic Proceedings|June 1, 1994
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experienceT M Pisansky, M Y Halyard, A L Weaver, et al.
Pageof 63

Showing results (511-520 of 626) with videos related to

Sort By:
Pageof 63
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancerFritcher Emily G Barr, Amy C Degnim, Lynn C Hartmann, et al.
Gynecologic Oncology|May 8, 2009
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancerAbraham Peedicayil, Robert A Vierkant, Vijayalakshmi Shridhar, et al.
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Breast Cancer Research and Treatment|August 13, 2015
Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort StudyAziza Nassar, Daniel W Visscher, Amy C Degnim, et al.
Frontiers in Immunology|November 16, 2020
Analysis of Granulomatous Lymphocytic Interstitial Lung Disease Using Two Scoring Systems for Computed Tomography Scans-A Retrospective Cohort StudyJennifer J Meerburg, Ieneke J C Hartmann, Sigune Goldacker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2001
Cigarette smoking increases risk for breast cancer in high-risk breast cancer familiesF J Couch, J R Cerhan, R A Vierkant, et al.
Cancer|June 29, 2016
Breast cancer risk by the extent and type of atypical hyperplasiaAmy C Degnim, Daniel W Visscher, Derek C Radisky, et al.
Gynecologic Oncology|April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinomaS John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Mayo Clinic Proceedings|June 1, 1994
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experienceT M Pisansky, M Y Halyard, A L Weaver, et al.
Pageof 63